279 related articles for article (PubMed ID: 22802261)
1. The p38 MAPK-MK2 axis regulates E2F1 and FOXM1 expression after epirubicin treatment.
de Olano N; Koo CY; Monteiro LJ; Pinto PH; Gomes AR; Aligue R; Lam EW
Mol Cancer Res; 2012 Sep; 10(9):1189-202. PubMed ID: 22802261
[TBL] [Abstract][Full Text] [Related]
2. ATM and p53 regulate FOXM1 expression via E2F in breast cancer epirubicin treatment and resistance.
Millour J; de Olano N; Horimoto Y; Monteiro LJ; Langer JK; Aligue R; Hajji N; Lam EW
Mol Cancer Ther; 2011 Jun; 10(6):1046-58. PubMed ID: 21518729
[TBL] [Abstract][Full Text] [Related]
3. Cytokine regulation by MAPK activated kinase 2 in keratinocytes exposed to sulfur mustard.
Yego EC; Dillman JF
Toxicol In Vitro; 2013 Oct; 27(7):2067-75. PubMed ID: 23851002
[TBL] [Abstract][Full Text] [Related]
4. p38 MAP kinase and MAPKAP kinases MK2/3 cooperatively phosphorylate epithelial keratins.
Menon MB; Schwermann J; Singh AK; Franz-Wachtel M; Pabst O; Seidler U; Omary MB; Kotlyarov A; Gaestel M
J Biol Chem; 2010 Oct; 285(43):33242-33251. PubMed ID: 20724476
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of FOXO3a on Ser-7 by p38 promotes its nuclear localization in response to doxorubicin.
Ho KK; McGuire VA; Koo CY; Muir KW; de Olano N; Maifoshie E; Kelly DJ; McGovern UB; Monteiro LJ; Gomes AR; Nebreda AR; Campbell DG; Arthur JS; Lam EW
J Biol Chem; 2012 Jan; 287(2):1545-55. PubMed ID: 22128155
[TBL] [Abstract][Full Text] [Related]
6. IL-1β-induced and p38
Kulawik A; Engesser R; Ehlting C; Raue A; Albrecht U; Hahn B; Lehmann WD; Gaestel M; Klingmüller U; Häussinger D; Timmer J; Bode JG
J Biol Chem; 2017 Apr; 292(15):6291-6302. PubMed ID: 28223354
[TBL] [Abstract][Full Text] [Related]
7. OTUB1 inhibits the ubiquitination and degradation of FOXM1 in breast cancer and epirubicin resistance.
Karunarathna U; Kongsema M; Zona S; Gong C; Cabrera E; Gomes AR; Man EP; Khongkow P; Tsang JW; Khoo US; Medema RH; Freire R; Lam EW
Oncogene; 2016 Mar; 35(11):1433-44. PubMed ID: 26148240
[TBL] [Abstract][Full Text] [Related]
8. FOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistance.
Khongkow P; Karunarathna U; Khongkow M; Gong C; Gomes AR; Yagüe E; Monteiro LJ; Kongsema M; Zona S; Man EP; Tsang JW; Coombes RC; Wu KJ; Khoo US; Medema RH; Freire R; Lam EW
Oncogene; 2014 Aug; 33(32):4144-55. PubMed ID: 24141789
[TBL] [Abstract][Full Text] [Related]
9. p38 inhibition and not MK2 inhibition enhances the secretion of chemokines from TNF-α activated rheumatoid arthritis fibroblast-like synoviocytes.
Dulos J; Wijnands FP; van den Hurk-van Alebeek JA; van Vugt MJ; Rullmann JA; Schot JJ; de Groot MW; Wagenaars JL; van Ravestein-van Os R; Smets RL; Vink PM; Hofstra CL; Nelissen RL; van Eenennaam H
Clin Exp Rheumatol; 2013; 31(4):515-25. PubMed ID: 23558031
[TBL] [Abstract][Full Text] [Related]
10. Mitogen-activated protein kinase-activated protein kinase-2 (MK2) and its role in cell survival, inflammatory signaling, and migration in promoting cancer.
Morgan D; Berggren KL; Spiess CD; Smith HM; Tejwani A; Weir SJ; Lominska CE; Thomas SM; Gan GN
Mol Carcinog; 2022 Feb; 61(2):173-199. PubMed ID: 34559922
[TBL] [Abstract][Full Text] [Related]
11. The Forkhead Box M1 protein regulates BRIP1 expression and DNA damage repair in epirubicin treatment.
Monteiro LJ; Khongkow P; Kongsema M; Morris JR; Man C; Weekes D; Koo CY; Gomes AR; Pinto PH; Varghese V; Kenny LM; Charles Coombes R; Freire R; Medema RH; Lam EW
Oncogene; 2013 Sep; 32(39):4634-45. PubMed ID: 23108394
[TBL] [Abstract][Full Text] [Related]
12. MAPKAPK-2 modulates p38-MAPK localization and small heat shock protein phosphorylation but does not mediate the injury associated with p38-MAPK activation during myocardial ischemia.
Gorog DA; Jabr RI; Tanno M; Sarafraz N; Clark JE; Fisher SG; Cao XB; Bellahcene M; Dighe K; Kabir AM; Quinlan RA; Kato K; Gaestel M; Marber MS; Heads RJ
Cell Stress Chaperones; 2009 Sep; 14(5):477-89. PubMed ID: 19214782
[TBL] [Abstract][Full Text] [Related]
13. Phenotype-assisted transcriptome analysis identifies FOXM1 downstream from Ras-MKK3-p38 to regulate in vitro cellular invasion.
Behren A; Mühlen S; Acuna Sanhueza GA; Schwager C; Plinkert PK; Huber PE; Abdollahi A; Simon C
Oncogene; 2010 Mar; 29(10):1519-30. PubMed ID: 20023695
[TBL] [Abstract][Full Text] [Related]
14. Identification of a membrane Ig-induced p38 mitogen-activated protein kinase module that regulates cAMP response element binding protein phosphorylation and transcriptional activation in CH31 B cell lymphomas.
Swart JM; Bergeron DM; Chiles TC
J Immunol; 2000 Mar; 164(5):2311-9. PubMed ID: 10679065
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of Argonaute 2 at serine-387 facilitates its localization to processing bodies.
Zeng Y; Sankala H; Zhang X; Graves PR
Biochem J; 2008 Aug; 413(3):429-36. PubMed ID: 18476811
[TBL] [Abstract][Full Text] [Related]
16. HGFK1 inhibits bone metastasis in breast cancer through the TAK1/p38 MAPK signaling pathway.
Yao Y; Fang ZP; Chen H; Yue L; Min DL; Tang LN; Yu WX; Kung HF; Lin MC; Shen Z
Cancer Gene Ther; 2012 Sep; 19(9):601-8. PubMed ID: 22767217
[TBL] [Abstract][Full Text] [Related]
17. MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart.
Streicher JM; Ren S; Herschman H; Wang Y
Circ Res; 2010 Apr; 106(8):1434-43. PubMed ID: 20339119
[TBL] [Abstract][Full Text] [Related]
18. MAPKAPK-2-mediated LIM-kinase activation is critical for VEGF-induced actin remodeling and cell migration.
Kobayashi M; Nishita M; Mishima T; Ohashi K; Mizuno K
EMBO J; 2006 Feb; 25(4):713-26. PubMed ID: 16456544
[TBL] [Abstract][Full Text] [Related]
19. FoxM1 regulates growth factor-induced expression of kinase-interacting stathmin (KIS) to promote cell cycle progression.
Petrovic V; Costa RH; Lau LF; Raychaudhuri P; Tyner AL
J Biol Chem; 2008 Jan; 283(1):453-460. PubMed ID: 17984092
[TBL] [Abstract][Full Text] [Related]
20. Activation of c-Jun N-terminal kinase (JNK) by widely used specific p38 MAPK inhibitors SB202190 and SB203580: a MLK-3-MKK7-dependent mechanism.
Muniyappa H; Das KC
Cell Signal; 2008 Apr; 20(4):675-83. PubMed ID: 18222647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
